Internal Medicine, Nephrology · Chesapeake, VA
NPI
1700875606
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
300 Medical Pkwy, Suite 222
Chesapeake, VA, 23320
Phone (757) 436-5544
Groups this clinician bills Medicare through
Medicare paid, 2024
$173K
2,011 services
Medicare patients, 2024
533
Average age 75
Drug cost, 2024
$1.8M
1,046 prescriptions
Company payments, 2025
$1,002
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Timothy M Curley was code 99233 (hospital e&m - subsequent), 295 times for 113 patients. In total Timothy M Curley billed 2,011 services in 27 codes, and Medicare paid $173K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-02-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 295 | 113 | $92.59 | $27K |
| 90960 ESRD Related Services (not dialysis) | Office | 275 | 39 | $263.70 | $73K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 275 | 220 | $12.04 | $3,311 |
| 99232 Hospital E&M - Subsequent | Facility | 259 | 121 | $61.12 | $16K |
| 90970 ESRD Related Services (not dialysis) | Office | 188 | 23 | $7.41 | $1,394 |
| 99214 Office E&M - Established | Office | 170 | 126 | $69.50 | $12K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 115 | 45 | $43.19 | $4,967 |
| 99442 Telephone Services | Office | 87 | 78 | $55.28 | $4,809 |
| 99223 Hospital E&M - Initial | Facility | 65 | 62 | $128.63 | $8,361 |
| 81003 Clinical Chemistry | Office | 55 | 55 | $2.20 | $121 |
| 99204 Office E&M - New | Office | 52 | 52 | $111.52 | $5,799 |
| 99215 Office E&M - Established | Office | 46 | 38 | $99.10 | $4,558 |
| 99213 Office E&M - Established | Office | 30 | 29 | $57.37 | $1,721 |
| 99222 Hospital E&M - Initial | Facility | 28 | 28 | $101.97 | $2,855 |
| 99443 Telephone Services | Office | 11 | 11 | $55.32 | $609 |
By year: 2022 $179K for 1,570 services; 2023 $167K for 1,565 services; 2024 $173K for 2,011 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 55 | 55 | $2.20 | $121 |
Medicare prescription drug claims, 2024
In 2024, the drug Timothy M Curley prescribed most often to Medicare patients was Spironolactone, with 65 prescriptions and refills. In total Timothy M Curley wrote 1,046 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Spironolactone Generic | 65 | 175 | 18 | $766 |
| Losartan Potassium Generic | 63 | 160 | 25 | $512 |
| Lisinopril Generic | 56 | 158 | 18 | $301 |
| Amlodipine Besylate Generic | 49 | 135 | 17 | $289 |
| Hydralazine Hcl Generic | 46 | 121 | 16 | $973 |
| Allopurinol Generic | 38 | 114 | Under 11 | $447 |
| Furosemide Generic | 37 | 81 | 12 | $232 |
| Olmesartan Medoxomil Generic | 36 | 84 | 13 | $380 |
| Farxiga Dapagliflozin Propanediol | 32 | 42 | Under 11 | $23K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 30 | 60 | Under 11 | $429 |
| Chlorthalidone Generic | 27 | 82 | 13 | $548 |
| Procysbi Cysteamine Bitartrate | 26 | 26 | Under 11 | $1.6M |
| Carvedilol Generic | 26 | 76 | 11 | $250 |
| Prednisone Generic | 24 | 58 | Under 11 | $212 |
| Clonidine Hcl Generic | 21 | 37 | Under 11 | $171 |
Brand drugs: 105 claims; generic drugs: 941 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Timothy M Curley $1,002 ($1,002 in general payments such as food, travel and fees) from 20 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $197.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 8 | $197 |
| Amgen Inc. AMGN | 6 | $124 |
| Bard Peripheral Vascular, Inc. BDX | 1 | $117 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $101 |
| Scpharmaceuticals Inc. SCPH | 3 | $71.09 |
| Ardelyx, Inc. ARDX | 3 | $62.78 |
| Akebia Therapeutics Inc AKBA | 2 | $48.75 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $44.48 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $29.91 |
| Travere Therapeutics, Inc. TVTX | 3 | $28.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.